01 1CKD Bio Corporation
01 1RIFAMPIN
01 1South Korea
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2013-10-04
Pay. Date : 2013-09-26
DMF Number : 13663
Submission : 1998-09-01
Status : Active
Type : II
20
Ckd Bio Corp, based in South Korea, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is RIFAMPIN, with a corresponding US DMF Number 13663.
Remarkably, this DMF maintains an Active status since its submission on September 01, 1998, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 04, 2013, and payment made on September 26, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II
